Skip to main content
Reviews in Obstetrics and Gynecology logoLink to Reviews in Obstetrics and Gynecology
. 2009 Winter;2(1):66–67.

Hormonal Contraception and Bone Mineral Density

Athol Kent 1
PMCID: PMC2673005  PMID: 19399298

Effects of Depot Medroxyprogesterone Acetate and 20-Microgram Oral Contraceptives on Bone Mineral Density

Berenson AB, Rahman M, Breitkopf CR, Bi LX.

Obstet Gynecol 2008;112:788–799.

Hormonal contraceptives negatively affect bone mass density (BMD), but the effect is small and reversible. Low-dose OCs in young women are associated with less than 0.5% BMD loss in the hip and spine.

Berenson and colleagues also looked at BMD changes with DMPA and found up to a 5% loss. This is potentially significant in young women. They discovered that the effect was temporary and those who stopped using DMPA gained BMD at about 2.5% per year.

Overall, the benefits of hormonal contraception far outweigh the risks.

Footnotes

These summaries are reproduced from the Journal Article Summary Service, a monthly publication summarizing clinically relevant articles from the recent world literature. Please see http://www.jassonline.com or e-mail atholkent@mweb.co.za for more information.


Articles from Reviews in Obstetrics and Gynecology are provided here courtesy of MedReviews, LLC

RESOURCES